Health Canada says 2nd impurity found in recalled China-made blood pressure drug valsartan
A second impurity that is a classified as a probable human carcinogen has been found in valsartan, manufactured by Zhejiang Huahai Pharmaceuticals in China, Health Canada announces.
Aucun commentaire:
Enregistrer un commentaire